本文已被:浏览 17次 下载 4次
投稿时间:2025-08-05 网络发布日期:2026-05-22
投稿时间:2025-08-05 网络发布日期:2026-05-22
中文摘要: 结直肠癌(CRC)是最常见的癌症之一,总体死亡率高,其早期诊断被认为是提高CRC患者生存率的有效方法。结直肠癌的发生、发展与多种因素相关,近年来,肠道菌群与CRC间的关系受到了广泛的关注,大量研究已经表明肠道菌群在结直肠癌发生发展以及转移方面发挥着重要作用,并可能作为疾病筛查、预后评估和治疗效果预测的生物标志物,而这也有望为临床应用提供新的机遇。本文综合最新研究进展,综述了肠道菌群组成特征及其介导CRC发生发展的机制,重点阐述了其在疾病诊断与治疗中的临床应用价值,旨在为CRC精准诊疗提供新策略。
Abstract:Colorectal cancer(CRC)is one of the most prevalent cancers with a high overall mortality rate,and its early diagnosis is
recognized as an effective strategy to improve survival rates among CRC patients. The occurrence and progression of CRC are associated with multiple factors. In recent years,the relationship between gut microbiota and CRC has garnered extensive attention. Numerous studies have indicated that gut microbiota play pivotal roles in the initiation,progression,and metastasis of CRC,and has the potential to serve as a biomarker for disease screening,prognosis,and treatment outcome prediction,which may offer new opportunities for clinical applications. This review synthesizes recent research advances,summarizes the compositional characteristics of the gut microbiota and the mechanisms by which they mediate the occurrence and progression of CRC,and focuses on elaborating their clinical application value in disease diagnosis and treatment,aiming to provide new strategies for the precise diagnosis and treatment of CRC.
文章编号: 中图分类号:R735.3 文献标志码:A
基金项目:2025年度无锡市卫生健康委科研项目(M202506)
附件
| Author Name | Affiliation |
| YAN Shusheng,WANG Tong,SHEN Renhui,MIAO Xiaofei | Department of Laparoscopic Surgery,Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi,Jiangsu 214000,China |
引用文本:
闫树盛, 王彤, 沈仁辉, 缪小飞.肠道菌群作为结直肠癌生物标志物的研究进展[J].中国临床研究,2026,39(5):794-798.
闫树盛, 王彤, 沈仁辉, 缪小飞.肠道菌群作为结直肠癌生物标志物的研究进展[J].中国临床研究,2026,39(5):794-798.
